N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141811 |
| CAS No | NA |
| Mol.F. | C16H15N3O7 |
| Mol.Wt. | 361.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141812 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141813 |
| CAS No | NA |
| Mol.F. | C35H36N4O7 |
| Mol.Wt. | 624.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141814 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141815 |
| CAS No | NA |
| Mol.F. | C22H22N8O2 |
| Mol.Wt. | 430.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141816 |
| CAS No | NA |
| Mol.F. | C11H19N3O3 |
| Mol.Wt. | 241.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141817 |
| CAS No | NA |
| Mol.F. | C6H10N4O2 |
| Mol.Wt. | 170.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141818 |
| CAS No | NA |
| Mol.F. | C6H10N2O5 |
| Mol.Wt. | 190.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141819 |
| CAS No | NA |
| Mol.F. | C28H34N4O9 |
| Mol.Wt. | 570.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141820 |
| CAS No | NA |
| Mol.F. | C20H20N4O2 |
| Mol.Wt. | 348.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141821 |
| CAS No | NA |
| Mol.F. | C20H21F3N4OS |
| Mol.Wt. | 422.g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141822 |
| CAS No | NA |
| Mol.F. | C8H13N3OS |
| Mol.Wt. | 199.27 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141823 |
| CAS No | 80-11-5 |
| Mol.F. | C8H10N2O3S |
| Mol.Wt. | 214.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141824 |
| CAS No | NA |
| Mol.F. | C19H22N2O2 |
| Mol.Wt. | 310.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141825 |
| CAS No | NA |
| Mol.F. | C21H22N2O3 |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141826 |
| CAS No | NA |
| Mol.F. | C11H19N3O5 |
| Mol.Wt. | 273.29 |
| INV STATUS | In Stock |